Updates from The Motley Fool

Latest updates on Dechra Pharmaceuticals from Fool.com.

Stock Performance

DPH vs. S&P 500 | 2 Year Performance
DPH 1-Day Stock Chart
DPH 5-Day Stock Chart
DPH 1-Month Stock Chart
DPH 3-Month Stock Chart
DPH 6-Month Stock Chart
DPH 1-Year Stock Chart
DPH 2-Year Stock Chart
DPH 5-Year Stock Chart
View Interactive DPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Dechra Pharmaceuticals.
Current Price: $1,169.00
Prev Close: $1,168.00
Open: $1,188.00
Bid: $0.00
Ask: $0.00
Day's Range: $1,164.00 - $1,188.00
52wk Range: $902.50 - $1,250.00
Volume: 0
Avg Vol 222,808
Market Cap: $108.39B
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Dechra Pharmaceuticals.
CAPS Rating 0 out of 5
0 Outperform
0 Underperform
CAPS All Stars
0 Outperform
0 Underperform

How do you think Dechra Pharmaceuticals will perform against the market?

You pick for Dechra Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Dechra Pharmaceuticals.

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. It listed in London in 2000.

  • Exchange: LSE